{
  "doc_id": "62393cb3428c3b722c1f88bf89ed2f17df4d54f17ac6260cf192353363687cf1",
  "chunk_entities": [
    {
      "chunk_id": "9fbc5fcb33450bad16a7047adae8a8fd",
      "entities": [
        {
          "entity_type": "Effect",
          "entity_name": "reducing age-related cognitive decline",
          "context": "reducing age-related cognitive decline"
        },
        {
          "entity_type": "Disease",
          "entity_name": "age-related cognitive decline",
          "context": "reducing age-related cognitive decline"
        },
        {
          "entity_type": "Effect",
          "entity_name": "preventing Alzheimer's dementia",
          "context": "preventing Alzheimer's dementia"
        },
        {
          "entity_type": "Disease",
          "entity_name": "Alzheimer's dementia",
          "context": "preventing Alzheimer's dementia"
        },
        {
          "entity_type": "Effect",
          "entity_name": "boost cognitive reserve",
          "context": "boost \"cognitive reserve\""
        },
        {
          "entity_type": "Effect",
          "entity_name": "consolidate cognitive maintenance",
          "context": "consolidate \"cognitive maintenance\""
        }
      ]
    },
    {
      "chunk_id": "ce40ac6522397fc3eb6f4d372fcba280",
      "entities": [
        {
          "entity_type": "Compound",
          "entity_name": "alkaloids",
          "context": "four alkaloids"
        },
        {
          "entity_type": "Compound",
          "entity_name": "Mesembrenol",
          "context": "alkaloids: Mesembrenol"
        },
        {
          "entity_type": "Compound",
          "entity_name": "Mesembrenone",
          "context": "Mesembrenol, Mesembrenone"
        },
        {
          "entity_type": "Compound",
          "entity_name": "Mesembrine",
          "context": "Mesembrenone, Mesembrine"
        },
        {
          "entity_type": "Compound",
          "entity_name": "Mesembranol",
          "context": "Mesembrine, and Mesembranol"
        },
        {
          "entity_type": "Compound",
          "entity_name": "piperidine ring",
          "context": "a piperidine ring"
        },
        {
          "entity_type": "Compound",
          "entity_name": "cyclohexene ring",
          "context": "a cyclohexene ring"
        },
        {
          "entity_type": "Compound",
          "entity_name": "benzene ring",
          "context": "a benzene ring"
        },
        {
          "entity_type": "Compound",
          "entity_name": "methoxy groups",
          "context": "two methoxy groups"
        },
        {
          "entity_type": "Compound",
          "entity_name": "OCH3",
          "context": "methoxy groups (OCH3)"
        },
        {
          "entity_type": "Compound",
          "entity_name": "hydroxyl group",
          "context": "a hydroxyl group"
        },
        {
          "entity_type": "Compound",
          "entity_name": "OH",
          "context": "hydroxyl group (OH)"
        },
        {
          "entity_type": "Compound",
          "entity_name": "ketone group",
          "context": "a ketone group"
        },
        {
          "entity_type": "Compound",
          "entity_name": "=O",
          "context": "ketone group (=O)"
        },
        {
          "entity_type": "Compound",
          "entity_name": "methyl group",
          "context": "a methyl group"
        },
        {
          "entity_type": "Compound",
          "entity_name": "CH3",
          "context": "methyl group (CH3)"
        }
      ]
    },
    {
      "chunk_id": "d981bf87f408e0552307dd93d8634b3f",
      "entities": [
        {
          "entity_type": "Disease",
          "entity_name": "psychiatric disorders",
          "context": "structured clinical interview for psychiatric disorders"
        },
        {
          "entity_type": "Disease",
          "entity_name": "DSM IV-R psychiatric disorders",
          "context": "any DSM IV-R psychiatric disorders"
        },
        {
          "entity_type": "Disease",
          "entity_name": "medical disorders",
          "context": "any significant and untreated medical disorders"
        },
        {
          "entity_type": "Disease",
          "entity_name": "severe uncontrolled or marginal glycemic controlled diabetes mellitus",
          "context": "marginal glycemic controlled diabetes mellitus"
        },
        {
          "entity_type": "Disease",
          "entity_name": "myocardial ischemia",
          "context": "recent myocardial ischemia"
        },
        {
          "entity_type": "Disease",
          "entity_name": "infarction",
          "context": "myocardial ischemia or infarction"
        },
        {
          "entity_type": "Disease",
          "entity_name": "unstable angina",
          "context": "unstable angina"
        },
        {
          "entity_type": "Disease",
          "entity_name": "uncontrolled hypertension",
          "context": "uncontrolled hypertension"
        },
        {
          "entity_type": "Disease",
          "entity_name": "renal failure",
          "context": "renal failure"
        },
        {
          "entity_type": "Disease",
          "entity_name": "serious renal diseases",
          "context": "serious renal diseases"
        },
        {
          "entity_type": "Disease",
          "entity_name": "chronic active hepatitis",
          "context": "chronic active hepatitis"
        },
        {
          "entity_type": "Disease",
          "entity_name": "acute hepatitis",
          "context": "acute hepatitis"
        },
        {
          "entity_type": "Disease",
          "entity_name": "cirrhosis of liver",
          "context": "cirrhosis of liver"
        },
        {
          "entity_type": "Disease",
          "entity_name": "AIDS",
          "context": "AIDS"
        },
        {
          "entity_type": "Disease",
          "entity_name": "malignancy",
          "context": "malignancy"
        },
        {
          "entity_type": "Disease",
          "entity_name": "neurological disorders",
          "context": "neurological disorders"
        },
        {
          "entity_type": "Disease",
          "entity_name": "epilepsy",
          "context": "epilepsy"
        },
        {
          "entity_type": "Disease",
          "entity_name": "recent cerebrovascular disease",
          "context": "recent cerebrovascular disease"
        },
        {
          "entity_type": "Disease",
          "entity_name": "recent traumatic brain injury",
          "context": "recent traumatic brain injury"
        },
        {
          "entity_type": "Disease",
          "entity_name": "active suicidal risk",
          "context": "active suicidal risk were also excluded"
        },
        {
          "entity_type": "Disease",
          "entity_name": "Hamilton depression",
          "context": "HAM-D (Hamilton depression)"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "score >/-8",
          "context": "HAM-D (Hamilton depression) [23] score >/-8"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "BMI >/-30.0",
          "context": "body mass index BMI >/-30.0"
        }
      ]
    },
    {
      "chunk_id": "c18e2b191204c88ad0ec11f1f20bfd6e",
      "entities": [
        {
          "entity_type": "Plant",
          "entity_name": "Sceletium tortuosum",
          "context": "received extract Sceletium tortuosum (Zembrin)"
        },
        {
          "entity_type": "Compound",
          "entity_name": "Zembrin",
          "context": "extract Sceletium tortuosum (Zembrin)"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "25 mg capsule",
          "context": "received extract Sceletium tortuosum (Zembrin) 25 mg capsule"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "25 mg capsule of Zembrin once daily orally",
          "context": "took a 25 mg capsule of Zembrin once daily orally"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "25 mg Zembrin capsule once daily orally",
          "context": "took the 25 mg Zembrin capsule once daily orally"
        }
      ]
    },
    {
      "chunk_id": "e8077507c2b383de0f6cb2444a8eb49f",
      "entities": [
        {
          "entity_type": "Compound",
          "entity_name": "Zembrin",
          "context": "Zembrin significantly improved cognitive flexibility"
        },
        {
          "entity_type": "Effect",
          "entity_name": "cognitive flexibility",
          "context": "improved cognitive flexibility"
        },
        {
          "entity_type": "Effect",
          "entity_name": "executive function",
          "context": "improved ... executive function"
        },
        {
          "entity_type": "Compound",
          "entity_name": "Zembrin",
          "context": "Zembrin improved processing speed"
        },
        {
          "entity_type": "Effect",
          "entity_name": "processing speed",
          "context": "improved processing speed"
        },
        {
          "entity_type": "Effect",
          "entity_name": "psychomotor speed",
          "context": "improved ... psychomotor speed"
        },
        {
          "entity_type": "Effect",
          "entity_name": "complex attention",
          "context": "improved ... complex attention"
        },
        {
          "entity_type": "Effect",
          "entity_name": "composite memory",
          "context": "in composite memory"
        },
        {
          "entity_type": "Effect",
          "entity_name": "verbal memory",
          "context": "in ... verbal memory"
        },
        {
          "entity_type": "Effect",
          "entity_name": "visual memory",
          "context": "in ... visual memory"
        },
        {
          "entity_type": "Compound",
          "entity_name": "Zembrin",
          "context": "Zembrin groups showed negative change"
        },
        {
          "entity_type": "Effect",
          "entity_name": "visual memory",
          "context": "in the domain of visual memory"
        },
        {
          "entity_type": "Effect",
          "entity_name": "visual memory",
          "context": "the final visual memory score"
        },
        {
          "entity_type": "Effect",
          "entity_name": "visual memory",
          "context": "the baseline visual memory score"
        }
      ]
    },
    {
      "chunk_id": "55b913dbb84580adba238c03874c6123",
      "entities": [
        {
          "entity_type": "Plant",
          "entity_name": "Sceletium tortuosum",
          "context": "extract Sceletium tortuosum (Zembrin)"
        },
        {
          "entity_type": "Effect",
          "entity_name": "generalized well-being",
          "context": "subjective ratings of generalized well-being"
        },
        {
          "entity_type": "Effect",
          "entity_name": "positive mood states",
          "context": "positive mood states in our study"
        },
        {
          "entity_type": "Effect",
          "entity_name": "uplifted spirits",
          "context": "reported \"uplifted spirits\""
        }
      ]
    },
    {
      "chunk_id": "ba8d906a3ee8586d6014cac3390d6e02",
      "entities": [
        {
          "entity_type": "Disease",
          "entity_name": "stress",
          "context": "coping with stress"
        },
        {
          "entity_type": "Disease",
          "entity_name": "depressing events",
          "context": "depressing events"
        },
        {
          "entity_type": "Disease",
          "entity_name": "HAM-D",
          "context": "baseline HAM-D scores"
        },
        {
          "entity_type": "Compound",
          "entity_name": "Zembrin",
          "context": "for the Zembrin group"
        },
        {
          "entity_type": "Effect",
          "entity_name": "decrease in HAM-D",
          "context": "a 13.8% decrease in HAM-D"
        }
      ]
    },
    {
      "chunk_id": "be6c39ce7dfcb463612a8f17a4cd748e",
      "entities": [
        {
          "entity_type": "Compound",
          "entity_name": "Zembrin extract",
          "context": "Zembrin extract effect"
        },
        {
          "entity_type": "Disease",
          "entity_name": "HAM-D",
          "context": "effect on HAM-D"
        }
      ]
    },
    {
      "chunk_id": "d84abe23a67ed1d8c37053a7182ebf71",
      "entities": [
        {
          "entity_type": "Compound",
          "entity_name": "Zembrin",
          "context": "Before Zembrin"
        },
        {
          "entity_type": "Compound",
          "entity_name": "Zembrin",
          "context": "After Zembrin"
        },
        {
          "entity_type": "Disease",
          "entity_name": "Depression",
          "context": "decrease on HAM-D"
        },
        {
          "entity_type": "Effect",
          "entity_name": "Decrease in depression symptoms",
          "context": "decrease on HAM-D"
        },
        {
          "entity_type": "Compound",
          "entity_name": "placebo",
          "context": "Before placebo"
        },
        {
          "entity_type": "Compound",
          "entity_name": "placebo",
          "context": "After placebo"
        }
      ]
    },
    {
      "chunk_id": "3b75ebc2f5df59b8d6c3808b4978eb27",
      "entities": [
        {
          "entity_type": "Compound",
          "entity_name": "Zembrin",
          "context": "The cognitive effects of Zembrin are consistent"
        },
        {
          "entity_type": "Compound",
          "entity_name": "PDE-4D3",
          "context": "long isoform of PDE-4D3"
        },
        {
          "entity_type": "Compound",
          "entity_name": "PDE-4B",
          "context": "human recombinant PDE-4B"
        },
        {
          "entity_type": "Compound",
          "entity_name": "mesembrenone",
          "context": "mesembrenone was 17 times more potent"
        },
        {
          "entity_type": "Compound",
          "entity_name": "mesembrine",
          "context": "more potent than mesembrine"
        },
        {
          "entity_type": "Compound",
          "entity_name": "mesembrenol",
          "context": "34 times more active than mesembrenol"
        },
        {
          "entity_type": "Compound",
          "entity_name": "rolipram",
          "context": "rolipram, the prototypical PDE-4 antagonist"
        },
        {
          "entity_type": "Compound",
          "entity_name": "PDE-4",
          "context": "prototypical PDE-4 antagonist"
        },
        {
          "entity_type": "Effect",
          "entity_name": "cognition",
          "context": "cognition is selectively mediated"
        },
        {
          "entity_type": "Effect",
          "entity_name": "inhibiting PDE-4B binding",
          "context": "inhibiting PDE-4B binding"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "470 nM",
          "context": "mesembrenone were 470 nM"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "7800 nM",
          "context": "mesembrine 7800 nM"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "10,000 nM",
          "context": "mesembrenol 10,000 nM"
        },
        {
          "entity_type": "Effect",
          "entity_name": "improve object retrieval performance",
          "context": "improve object retrieval performance"
        },
        {
          "entity_type": "Disease",
          "entity_name": "gastrointestinal side effects",
          "context": "absence of gastrointestinal side effects"
        }
      ]
    },
    {
      "chunk_id": "a7394bdf768b84b4c0669f0a69d4ca37",
      "entities": [
        {
          "entity_type": "Effect",
          "entity_name": "adverse events",
          "context": "Frequency of adverse events"
        },
        {
          "entity_type": "Compound",
          "entity_name": "Zembrin",
          "context": "Z: Zembrin treated group"
        }
      ]
    }
  ],
  "total_entities": 98,
  "extraction_date": "2026-02-01T08:32:55.066426+00:00"
}